CEREPRO (Choline Alfoscerate) is used for the restoration of brain activity and the treatment of cerebral diseases. The medication brings positive results during the treatment of traumatic brain injury and cerebrovascular disease. It can be helpful during chronic ischemic brain disease. The medication is prescribed as a part of basic therapy to be taken with other drugs prescribed by the physician. The active substance is choline alfoscerate that is a natural choline compound in the brain. The specialists explore the potential of the substance to determine if it’s possible to use the medication for Alzheimer’s disease and other kinds of dementia.
The delivery of the active substance occurs rather fast. It is a biosynthetic precursor of acetylcholine, acting as a neurotransmitter that motors neurons of the nervous system release for activation of muscles.
- Improves blood flow and metabolic processes in the central nervous system.
- Removes the symptoms of brain stem damage.
- Helps to alleviate the symptoms of cerebrovascular disease.
- Improves the condition of patients with motor and coordination disturbances.
- Stabilizes emotional and cognitive state of the patient.
- Contributes to the restoration of lost functions in the patient’s body.
The preparation is 100% original from AO Veropharm, Russia. Expiry up to 10.2024.
The drug includes metabolically protected choline that releases in the brain. Entering the body, the preparation is split by enzymes. As a result of this split, the patient gets glycerophosphate, which is a precursor of phospholipids of the neuronal membrane, and choline that is involved in the biological synthesis of acetylcholine, which belongs to the most important mediators of the nervous excitement. With the synthesis of acetylcholine and phosphatidylcholine in neuronal membranes, the medication enhances blood flow and improves the metabolism of the central nervous system. It activates the formation of the connective tissue, so the medication can be very helpful for the patients with traumatic brain damage. It improves the characteristics of bioelectric brain activity. In general, the medication produces a favorable effect on cognitive functions and behavioral responses in people diagnosed with cerebrovascular diseases.
The medication easily penetrates the blood-brain barrier. 88% of the medicine is absorbed, while the oral intake of medication helps to reach a concentration of 45% in the brain of the patient. The excretion is performed via the lungs. 85% of it is excreted as carbon dioxide and only 15% refers to kidneys and intestine.
The medication is well tolerated, as a rule. It comes in 400 mg capsules that contain 400 mg of choline alfoscerate. The doctor usually prescribes 400 mg cerepro (1 capsule) three times a day, which should be taken preferably before meals.
At a temperature not exceeding 25° C. Keep out of the reach of children.
Ask us any questions about CEREPRO.